BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34329659)

  • 1. Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal-Regulated Kinase 1/2 Module in Human Skin Mast Cells.
    Wang Z; Franke K; Zuberbier T; Babina M
    J Invest Dermatol; 2022 Feb; 142(2):414-424.e8. PubMed ID: 34329659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2.
    Franke K; Wang Z; Zuberbier T; Babina M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.
    Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M
    Cells; 2019 Apr; 8(4):. PubMed ID: 30979016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of G
    Wang Z; Franke K; Bal G; Li Z; Zuberbier T; Babina M
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture.
    Babina M; Wang Z; Artuc M; Guhl S; Zuberbier T
    Exp Dermatol; 2018 Nov; 27(11):1298-1303. PubMed ID: 30091263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK.
    Babina M; Wang Z; Franke K; Zuberbier T
    Cells; 2021 Jan; 10(1):. PubMed ID: 33429916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between IL-33 and MRGPRX2/FcεRI Is Primarily Due to the Complementation of Signaling Modules, and Only Modestly Supplemented by Prolonged Activation of Selected Kinases.
    Franke K; Li Z; Bal G; Zuberbier T; Babina M
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood cultured mast cells: Phenotypic and functional outcomes of different culture protocols.
    Elst J; Sabato V; van der Poorten MM; Faber M; Van Gasse AL; De Puysseleyr LP; Bridts CH; Mertens C; Van Houdt M; Maurer M; Hagendorens MM; Ebo DG
    J Immunol Methods; 2021 May; 492():113003. PubMed ID: 33647250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
    Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
    Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway.
    Babina M; Wang Z; Roy S; Guhl S; Franke K; Artuc M; Ali H; Zuberbier T
    J Invest Dermatol; 2021 May; 141(5):1286-1296.e4. PubMed ID: 33058860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
    Roy S; Ganguly A; Haque M; Ali H
    J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
    Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
    Front Immunol; 2021; 12():625284. PubMed ID: 33790895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
    Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
    Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic FcεRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF.
    Babina M; Guhl S; Artuc M; Zuberbier T
    Allergy; 2018 Jan; 73(1):256-260. PubMed ID: 28859248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
    Thapaliya M; Ali H
    Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
    Baldo BA
    Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
    Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
    Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells.
    Chaki S; Alkanfari I; Roy S; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
    Front Immunol; 2021; 12():803335. PubMed ID: 35126366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRGPRX2 signals its importance in cutaneous mast cell biology: Does MRGPRX2 connect mast cells and atopic dermatitis?
    Wang Z; Babina M
    Exp Dermatol; 2020 Nov; 29(11):1104-1111. PubMed ID: 32866307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
    Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
    J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.